1 |
Subgroup analysis of a phase 2/3 study of rurioctocog alfa pegol in patients with severe hemophilia A: efficacy and safety in previously treated Korean patients
Chur Woo You, Hee Jo Baek, Sang Kyu Park, Young Shil Park, Ho-Jin Shin, Werner Engl, Srilatha Tangada
Blood Res.2019;54(3):198-203. Published online 2019 September 25
DOI: http://dx.doi.org/10.5045/br.2019.54.3.198
|
|